Recruiting
Phase 1
Phase 2

MRT-2359

Sponsor:

Monte Rosa Therapeutics, Inc

Code:

NCT05546268

Conditions

NSCLC

SCLC

High Grade Neuroendocrine Cancer

DLBCL

L-MYC and N-MYC Amplified Solid Tumors

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Oral MRT-2359

Oral MRT-2359

Oral MRT-2359

Oral MRT-2359

Oral MRT-2359

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-01-07. This information was provided to ClinicalTrials.gov by Monte Rosa Therapeutics, Inc on 2025-10-22.